AzTrials
AzTrials

Critical IllnessIPREA3NCT02442934

Reducing Discomforts in Critically Ill Patients: the IPREA3 Study

A study testing Administration of the IPREA3 questionnaire, Immediate feedback through electronic reminder messages and Targeted interventions in each ICU to reduce discomforts in people with Critical Illness, run by Dr Pierre KALFON at 26 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Since critically ill patients are exposed to stressful conditions, the investigators evaluated the effectiveness of a multicomponent program to reduce perceived discomforts in the Intensive Care Unit (ICU) . Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critical Illness
What is being tested?
Administration of the IPREA3 questionnaire, Immediate feedback through electronic reminder messages and Targeted interventions in each ICU to reduce discomforts
Could I receive a placebo?
No, everyone receives an active treatment
How many people
5,411 participants
Where
26 sitesFrance
Study dates
Oct 2014to Oct 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult critically ill patients
  • ICU stay of three calendar days or more

Who cannot join

  • deceased patient in the ICU
  • ICU stay of two calendar days or less
  • patient younger than 18
  • patient under trusteeship
  • patient refusing to participate to the study
  • patient with diminished mental capacity
Show all 9Show fewer
  • patient not understanding French sufficiently to be questioned (language barrier)
  • transfer to another ICU while mechanically ventilated
  • emergency discharge

Trial locations and contacts

26 sites in 1 country.

26 sites in 1 country

France26 sites
  • CH Auxerre

    Auxerre, 89000

  • Hôpital de la Cavale Blanche

    Brest, 29609

  • CH Louis Pasteur

    Chartres, 28018

  • CHU Beaujon APHP

    Clichy, 92110

  • CHU Hôpital Bocage

    Dijon, 21079

  • CH Douai

    Douai, 59507

  • CHU Raymond Poincaré APHP

    Garches, 92380

  • CH La Rochelle

    La Rochelle, 17022

  • CH Le Puy en Velay

    Le Puy-en-Velay, 43000

  • CH Lens

    Lens, 62300

  • CHU Edouard Herriot

    Lyon, 69003

  • Hôpital Européen

    Marseille, 13003

  • CHU Hôpital Nord

    Marseille, 13005

  • Clinique Ambroise Paré

    Neuilly-sur-Seine, 92200

  • CHU Hôpital Pasteur2

    Nice, 06000

  • CHU Saint Louis APHP

    Paris, 75010

  • CHU La Pitié Salpétrière APHP

    Paris, 75013

  • CHU Cochin APHP

    Paris, 75014

  • Hôpital Saint Joseph

    Paris, 75014

  • CHU Hôpital Européen Georges Pompidou APHP

    Paris, 75015

  • CHU La Milétrie

    Poitiers, 86000

  • CH Victor Provo

    Roubaix, 59100

  • CHU NHC

    Strasbourg, 67000

  • CHU Hautepierre

    Strasbourg, 67100

  • Hôpital Saint Musse

    Toulon, 83100

  • CH Troyes

    Troyes, 10000

Other trials in France

About this study

Official title: A Multicomponent Intervention to Reduce Perceived Discomforts in Critically Ill Patients: a Randomized Controlled Trial

Since critically ill patients are exposed to stressful conditions, the investigators evaluated the effectiveness of a multicomponent program to reduce perceived discomforts in the Intensive Care Unit (ICU) .

Read the detailed description

The investigators conducted a cluster-randomized trial randomizing 34 ICUs. The program targeted staff members with 3 components : web-based systematic measurement of discomforts on the day of ICU discharge by institutional caregivers (nurses and assistant nurses of the participating ICU), immediate feedback through electronic reminder messages intended to caregivers, and targeted interventions in each ICU based on comparative discomfort scores monthly reported to local champions who were also responsible for staff education.

The measurement of discomforts perceived by critically ill patients at the end of the ICU stay, related to the whole stay in the ICU, was performed by the bedside nurse using a specific questionnaire, the IPREA questionnaire whose construct validity, external validity, reliability, reproducibility and acceptability have been already demonstrated (Development and validation of a questionnaire for quantitative assessment of perceived discomforts in critically ill patients. Kalfon P et al, Intensive care Med 2010, 36:1751-58). The version of the IPREA questionnaire used in the study was a 18-item questionnaire : noise ; excessive light ; discomfort related to sleeping in a different bed from home ; sleep deprivation ; thirst ; hunger ; feeling of cold ; feeling of heat ; pain ; being tied down by perfusion lines, tubes or as a result of connections due to monitoring devices ; no respect for intimacy ; anxiety ; isolation ; limited visiting hours ; absence of phone ; lack of information ; shortness of breath ; and depression.

The duration of the program is 6 months in each arm. Potential participants in the study were consecutive patients admitted in all the participating ICU that are divided in two groups of 17 ICUs.

During October 2014, the IPREA questionnaire is administered to all potentially eligible patients hospitalized in the 34 participating ICUs without applying the program (period P1). The 17 ICUs of the group 1 do not apply the multicomponent program during 5 months (until March 2015), while the 17 ICUs of the group 2 apply the program (period P2). During April 2015, the questionnaire IPREA is administered again in both groups (period P3). From May 2015 until September 2015, the multicomponent program is only applied in the group 1 and no longer in the group 2 (period P4) in order to achieve the crossover of the intervention. During October 2015, the questionnaire IPREA is administered again in both groups (period P5).

The overall score of discomfort and the scores for each item will be compared in the control arm and in the interventional arm.

The control arm consists in the patients included in the group 2 during October 2014 and the patients included in the group 1 during April 2015, i.e. patients included during the month preceding the implementation of the multicomponent program.

The interventional arm consists in the patients included in the group 2 during April 2015 and the patients included in the group 1 during October 2015, i.e. patients included during the last month of the period of application of the multicomponent program.

Being tested
Administration of the IPREA3 questionnaire, Immediate feedback through electronic reminder messages, Targeted interventions in each ICU to reduce discomforts
Keywords
Critical Care, Critical Care Nursing, Discomfort, Sleep deprivation, Noise, Thirst, Pain
Medical subject headings
Critical Illness, Sleep Deprivation, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Administration of the IPREA3 questionnaireOther

    On the day of the ICU discharge, the bedside nurse administers to the patient the 18-item IPREA questionnaire i.e the nurse asks the patient to rate the severity of each discomfort source contained in the IPREA3 questionnaire experienced during the entire stay in the ICU

  • Immediate feedback through electronic reminder messagesOther

    After the nurse had administered the questionnaire, warning messages are displayed on the screen corresponding to the key points to prevent the three discomforts reported with the highest scores

  • Targeted interventions in each ICU to reduce discomfortsOther

    These targeted interventions are implemented through the coordination of two local champions.

    The central coordination IPREA3 team sends each month to the local champions monthly and cumulative discomfort scores of their unit (overall score of discomfort and scores for each item) and their ranking relative to other units assigned to the interventional arm i.e applying the IPREA3 program.

    The local champions organize monthly meetings with the unit staff to present the results in terms of perceived discomforts measured by the IPREA questionnaire, identify main discomfort sources and actions to be conducted to reduce the discomforts reported with the highest scores in the unit and those that are most easily preventable, and assess the efficacy of already applied measures.

Study groups in NCT02442934
Study groupRoleWhat they receive
Multicomponent programExperimentalMulticomponent intervention to reduce perceived discomforts in critically ill patients : the IPREA3 program
Receives: Other: Administration of the IPREA3 questionnaire; Other: Immediate feedback through electronic reminder messages; Other: Targeted interventions in each ICU to reduce discomforts
Standard CareActive comparatorStandard care
Receives: Other: Administration of the IPREA3 questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall score of discomfort

    Each discomfort-item is scored 0-10 (example 0 = no pain ; 10 = pain as bad as can be). For each individual, the overall score of discomfort is computed as the mean of the 18 scores reported for each discomfort-item multiplied by 10, yielding an overall score between 0 and 100.

    Measured: 1 Day of discharge from the ICU

Secondary outcomes (1)
  1. Scores reported for each discomfort-item

    Each of the 18 discomfort-items is scored 0-10 (example 0 = no thirst ; 10 = thirst as bad as can be).

    Measured: 1 Day of discharge from the ICU

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2015 (estimated)
  2. Study startOct 2014
  3. Primary completionOct 2015
  4. Study completionOct 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
5,411 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02442934
Sponsor's protocol ID
2012-AO1696-37
Acronym
IPREA3
Status last verified
Mar 2016
First submitted
11 May 2015
Last updated
21 Mar 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes

Publications

  • Kalfon P, Mimoz O, Auquier P, Loundou A, Gauzit R, Lepape A, Laurens J, Garrigues B, Pottecher T, Malledant Y. Development and validation of a questionnaire for quantitative assessment of perceived discomforts in critically ill patients. Intensive Care Med. 2010 Oct;36(10):1751-1758. doi: 10.1007/s00134-010-1902-9. Epub 2010 May 26.

    PubMed 20502874
  • Kalfon P, Boucekine M, Estagnasie P, Geantot MA, Berric A, Simon G, Floccard B, Signouret T, Fromentin M, Nyunga M, Audibert J, Ben Salah A, Mauchien B, Sossou A, Venot M, Robert R, Follin A, Renault A, Garrouste-Orgeas M, Collange O, Levrat Q, Villard I, Thevenin D, Pottecher J, Patrigeon RG, Revel N, Vigne C, Azoulay E, Mimoz O, Auquier P, Baumstarck K; IPREA Study Group. Risk factors and events in the adult intensive care unit associated with pain as self-reported at the end of the intensive care unit stay. Crit Care. 2020 Dec 7;24(1):685. doi: 10.1186/s13054-020-03396-2.

    PubMed 33287910
  • Baumstarck K, Boucekine M, Estagnasie P, Geantot MA, Berric A, Simon G, Floccard B, Signouret T, Fromentin M, Nyunga M, Sossou A, Venot M, Robert R, Follin A, Audibert J, Renault A, Garrouste-Orgeas M, Collange O, Levrat Q, Villard I, Thevenin D, Pottecher J, Patrigeon RG, Revel N, Vigne C, Azoulay E, Mimoz O, Auquier P, Kalfon P; IPREA Study group. Assessment of patients' self-perceived intensive care unit discomforts: Validation of the 18-item version of the IPREA. Health Qual Life Outcomes. 2019 Feb 7;17(1):29. doi: 10.1186/s12955-019-1101-5.

    PubMed 30732654
  • Kalfon P, Baumstarck K, Estagnasie P, Geantot MA, Berric A, Simon G, Floccard B, Signouret T, Boucekine M, Fromentin M, Nyunga M, Sossou A, Venot M, Robert R, Follin A, Audibert J, Renault A, Garrouste-Orgeas M, Collange O, Levrat Q, Villard I, Thevenin D, Pottecher J, Patrigeon RG, Revel N, Vigne C, Azoulay E, Mimoz O, Auquier P; IPREA Study group. A tailored multicomponent program to reduce discomfort in critically ill patients: a cluster-randomized controlled trial. Intensive Care Med. 2017 Dec;43(12):1829-1840. doi: 10.1007/s00134-017-4991-x. Epub 2017 Nov 27.

    PubMed 29181557
  • Kalfon P, Mimoz O, Loundou A, Geantot MA, Revel N, Villard I, Amour J, Azoulay E, Garrouste-Orgeas M, Martin C, Sharshar T, Baumstarck K, Auquier P. Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial. Trials. 2016 Feb 16;17:87. doi: 10.1186/s13063-016-1211-x.

    PubMed 26880373

Questions about this trial

What is this clinical trial studying?

A study testing Administration of the IPREA3 questionnaire, Immediate feedback through electronic reminder messages and Targeted interventions in each ICU to reduce discomforts in people with Critical Illness, run by Dr Pierre KALFON at 26 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 26 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall score of discomfort (time frame: 1 Day of discharge from the ICU). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02442934, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in